You can be sure that all biotechnology companies, pharmaceuticals and medical research companies (especially others in the stem cell field) are watching ACTC and its trials very closely. This verification of a new frontier in science will affect MANY other companies pro or con. I am sure that other stem cell research companies are anxious to see positive results from this trial as it would also verify their own research. ACTC is at the forefront of all for commercialization and will be the first to reap the rewards of a successful trial, but this is a win win for ALL stem cell research companies. When news of trial success, all companies in this field will see shareholder value increase as the "doubt" of this science is totally washed away. The big Pharmas, on the other hand, also watching these trials, will have to re-evaluate their strategy going forward. Will they sit back and watch this new science put a serious hurt on their products (drugs) making some nearly useless or will they include this new science for cures into their arsenal of products for treatments. These are VERY powerful companies in both the medical AND FINANCIAL world. All one has to do is look at Wall Street and see the value that the markets put on companies such as MERCK, PFIZER, J&J, etc. I am betting that they will have no choice but to buy/partner with the first that verifies this science (ACTC).
